124 related articles for article (PubMed ID: 2541962)
1. Urinary excretion of meso-2,3-dimercaptosuccinic acid in human subjects.
Aposhian HV; Maiorino RM; Dart RC; Perry DF
Clin Pharmacol Ther; 1989 May; 45(5):520-6. PubMed ID: 2541962
[TBL] [Abstract][Full Text] [Related]
2. Determination and metabolism of dithiol chelating agents. IV. Urinary excretion of meso-2,3-dimercaptosuccinic acid and mercaptosuccinic acid in rabbits given meso-2,3-dimercaptosuccinic acid.
Maiorino RM; Aposhian HV
Biochem Pharmacol; 1989 Apr; 38(7):1147-54. PubMed ID: 2539817
[TBL] [Abstract][Full Text] [Related]
3. Determination and metabolism of dithiol chelating agents. VI. Isolation and identification of the mixed disulfides of meso-2,3-dimercaptosuccinic acid with L-cysteine in human urine.
Maiorino RM; Bruce DC; Aposhian HV
Toxicol Appl Pharmacol; 1989 Feb; 97(2):338-49. PubMed ID: 2538007
[TBL] [Abstract][Full Text] [Related]
4. Determination and metabolism of dithiol chelating agents: X. In humans, meso-2,3-dimercaptosuccinic acid is bound to plasma proteins via mixed disulfide formation.
Maiorino RM; Akins JM; Blaha K; Carter DE; Aposhian HV
J Pharmacol Exp Ther; 1990 Aug; 254(2):570-7. PubMed ID: 2166796
[TBL] [Abstract][Full Text] [Related]
5. Renal handling of technetium-99m DMSA: evidence for glomerular filtration and peritubular uptake.
de Lange MJ; Piers DA; Kosterink JG; van Luijk WH; Meijer S; de Zeeuw D; van der Hem GK
J Nucl Med; 1989 Jul; 30(7):1219-23. PubMed ID: 2544699
[TBL] [Abstract][Full Text] [Related]
6. meso-2,3-Dimercaptosuccinic acid: chemical, pharmacological and toxicological properties of an orally effective metal chelating agent.
Aposhian HV; Aposhian MM
Annu Rev Pharmacol Toxicol; 1990; 30():279-306. PubMed ID: 2160791
[TBL] [Abstract][Full Text] [Related]
7. Dimercaptosuccinic acid (succimer; DMSA) in inorganic lead poisoning.
Bradberry S; Vale A
Clin Toxicol (Phila); 2009 Aug; 47(7):617-31. PubMed ID: 19663612
[TBL] [Abstract][Full Text] [Related]
8. Analysis of meso-2,3-dimercaptosuccinic acid in human urine by capillary electrophoresis using direct injection.
Zhu X; Lever SZ
Anal Bioanal Chem; 2003 Oct; 377(4):666-9. PubMed ID: 12904952
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of meso-2,3-dimercaptosuccinic acid in lead-poisoned children and normal adults.
Asiedu P; Moulton T; Blum CB; Roldan E; Lolacono NJ; Graziano JH
Environ Health Perspect; 1995; 103(7-8):734-9. PubMed ID: 7588486
[TBL] [Abstract][Full Text] [Related]
10. Determination and metabolism of dithiol chelating agents. XV. The meso-2,3-dimercaptosuccinic acid-cysteine (1:2) mixed disulfide, a major urinary metabolite of DMSA in the human, increases the urinary excretion of lead in the rat.
Maiorino RM; Aposhian MM; Xu ZF; Li Y; Polt RL; Aposhian HV
J Pharmacol Exp Ther; 1993 Dec; 267(3):1221-6. PubMed ID: 8263783
[TBL] [Abstract][Full Text] [Related]
11. The presence of lead decreases the availability of meso-2, 3-dimercaptosuccinic acid for analysis in the monobromobimane assay.
Lever SZ; Parsons TL
Chem Res Toxicol; 1999 Nov; 12(11):1057-65. PubMed ID: 10563831
[TBL] [Abstract][Full Text] [Related]
12. A kinetic model for 99mTc-DMSA in the rat.
Maneval DC; D'Argenio DZ; Wolf W
Eur J Nucl Med; 1990; 16(1):29-34. PubMed ID: 2155115
[TBL] [Abstract][Full Text] [Related]
13. Gas chromatographic analysis of urinary dimercaptosuccinic acid.
Knudsen JJ; McGown EL
J Chromatogr; 1988 Feb; 424(2):231-41. PubMed ID: 2836447
[TBL] [Abstract][Full Text] [Related]
14. Human studies with the chelating agents, DMPS and DMSA.
Aposhian HV; Maiorino RM; Rivera M; Bruce DC; Dart RC; Hurlbut KM; Levine DJ; Zheng W; Fernando Q; Carter D
J Toxicol Clin Toxicol; 1992; 30(4):505-28. PubMed ID: 1331491
[TBL] [Abstract][Full Text] [Related]
15. Determination and metabolism of dithiol chelating agents. VII. Biliary excretion of dithiols and their interactions with cadmium and metallothionein.
Zheng W; Maiorino RM; Brendel K; Aposhian HV
Fundam Appl Toxicol; 1990 Apr; 14(3):598-607. PubMed ID: 2160390
[TBL] [Abstract][Full Text] [Related]
16. Urinary excretion of mercury after occupational exposure to mercury vapour and influence of the chelating agent meso-2,3-dimercaptosuccinic acid (DMSA).
Roels HA; Boeckx M; Ceulemans E; Lauwerys RR
Br J Ind Med; 1991 Apr; 48(4):247-53. PubMed ID: 1851035
[TBL] [Abstract][Full Text] [Related]
17. Determination and metabolism of dithiol chelating agents. VIII. Metal complexes of meso-dimercaptosuccinic acid.
Rivera M; Zheng W; Aposhian HV; Fernando Q
Toxicol Appl Pharmacol; 1989 Aug; 100(1):96-106. PubMed ID: 2548305
[TBL] [Abstract][Full Text] [Related]
18. 99Tcm-diastereomeric dimercaptosuccinic acid complexes: comparison of their biodistribution.
Awh OD; Kim JR; Shim SC
Nucl Med Commun; 1989 Jun; 10(6):449-54. PubMed ID: 2549480
[TBL] [Abstract][Full Text] [Related]
19. delta-Aminolevulinic acid dehydratase genotype modifies four hour urinary lead excretion after oral administration of dimercaptosuccinic acid.
Schwartz BS; Lee BK; Stewart W; Sithisarankul P; Strickland PT; Ahn KD; Kelsey K
Occup Environ Med; 1997 Apr; 54(4):241-6. PubMed ID: 9166129
[TBL] [Abstract][Full Text] [Related]
20. A comparison of sodium calcium edetate (edetate calcium disodium) and succimer (DMSA) in the treatment of inorganic lead poisoning.
Bradberry S; Vale A
Clin Toxicol (Phila); 2009 Nov; 47(9):841-58. PubMed ID: 19852620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
